Phillip Terry Meikle II
CIK: 0002041874
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bone Biologics Corp
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 4, 2025BBLG
Bone Biologics Corp
Award(A)DirectNon-Employee Stock Option
62.9K shares- - Oct 16, 2024BBLG
Bone Biologics Corp
Award(A)DirectNon-Employee Stock Option
9 shares- - Oct 16, 2024BBLG
Bone Biologics Corp
Award(A)DirectNon-Employee Stock Option
28.2K shares-
1-3 of 3 transactions
About Meikle Phillip Terry II
Meikle Phillip Terry II (SEC CIK 0002041874) files insider reports with the SEC as Director of Bone Biologics Corp (BBLG).
Signal8 holds 3 ownership filings by Meikle Phillip Terry II (1 Form 3, 2 Form 4), filed between Oct 18, 2024 and Jun 6, 2025. Those filings report 3 transactions, from Oct 16, 2024 to Jun 4, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Meikle Phillip Terry II's filings is in BURLINGTON, MA.
Recent filings by Meikle Phillip Terry II
Other insiders filing for Bone Biologics Corp (BBLG)
- Walsh Deina H, Chief Financial Officer
- Frelick Jeff, Chief Executive Officer
- Angle Siddhesh Rajendra, Director
- Stroever Bruce, Director
- Gagnon Robert E., Director